Overview
- The Office of Management and Budget unveiled the roughly 400‑page proposal on May 29 to convert parts of the federal Uniform Guidance into binding regulation that requires political appointees to review and approve most discretionary grants.
- The public comment period closed on July 13 with roughly 300,000 to 340,000 submissions, with scientific societies, universities, patient groups and thousands of individual researchers overwhelmingly opposing the changes.
- Major organizations including the American Chemical Society, American Physical Society, AAAS and large university groups filed formal comments saying the rule would sideline merit‑based peer review, enable arbitrary termination of multi‑year awards, and restrict international collaboration.
- Legal and legislative pushback is forming now as advocacy groups and higher‑education associations prepare Administrative Procedure Act lawsuits and urge Congress to intervene, citing vague national‑security exemptions and procedural defects.
- Experts and patient advocates warn the rule could disrupt clinical trials, chill collaboration and publishing, accelerate researcher departures and damage U.S. scientific competitiveness if OMB moves to finalize the rule by the October 1 target for new awards.